Literature DB >> 2769753

Regulatory and essential light-chain-binding sites in myosin heavy chain subfragment-1 mapped by site-directed mutagenesis.

E J Mitchell1, J Karn, D M Brown, A Newman, R Jakes, J Kendrick-Jones.   

Abstract

Site-directed mutagenesis of the cloned subfragment-1 (S-1) region of the unc-54 gene, encoding the myosin heavy chain B (MHC B) from Caenorhabditis elegans, has been used to locate binding sites for the regulatory and essential light chains. MHC B S-1 synthesized in Escherichia coli co-migrated with rabbit skeletal muscle myosin S-1 (Mr 90,000), was recognized by anti-nematode myosin antiserum on immunoblots, and specifically bound to 125I-labelled regulatory and essential light chains in a gel overlay assay. Deletion of 102 residues from the C terminus (mutant 655) reduced regulatory and essential light-chain binding to about 30% and 20% of wild-type levels, respectively. Similar reductions in relative binding of the two light chains were seen with mutant 534, in which 38 residues were deleted from the C terminus. Potential binding sites within 75 residues of the C terminus of S-1 were mapped by construction of five other mutant S-1 clones (398, 399, 400, 409 and 411) containing internal deletions of ten to 12 amino acid residues. These showed up to 30% reductions in their ability to bind essential light chains, but did not differ significantly from wild-type in their ability to bind regulatory light chains. Another mutant, 415, containing a deletion of a conserved acidic hexapeptide, E-D-I-R-D-E, showed enhancement of binding of regulatory and essential light chains to 150% and 165% of wild-type levels. Hence, the major binding sites for both light chains are within 38 amino acid residues of the C terminus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769753     DOI: 10.1016/0022-2836(89)90096-x

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Protein engineering and site-directed mutagenesis. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1990-10       Impact factor: 2.926

2.  Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.

Authors:  Hiroshi Deguchi; Zihan Guo; Mohammed Hayat; Elsa Pflimlin; Sam Lear; Weijun Shen; John H Griffin
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

3.  In vitro production of enzymatically active myosin heavy chain.

Authors:  H Rindt; B J Bauer; J Robbins
Journal:  J Muscle Res Cell Motil       Date:  1993-02       Impact factor: 2.698

4.  Mapping of the actomyosin interfaces.

Authors:  P Eldin; M Le Cunff; H P Vosberg; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

5.  Primary structure and cellular localization of chicken brain myosin-V (p190), an unconventional myosin with calmodulin light chains.

Authors:  E M Espreafico; R E Cheney; M Matteoli; A A Nascimento; P V De Camilli; R E Larson; M S Mooseker
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

6.  Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans.

Authors:  P G Okkema; S W Harrison; V Plunger; A Aryana; A Fire
Journal:  Genetics       Date:  1993-10       Impact factor: 4.562

7.  Identification of sequences necessary for the association of cardiac myosin subunits.

Authors:  E M McNally; M M Bravo-Zehnder; L A Leinwand
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

8.  Molecular features of the UNC-45 chaperone critical for binding and folding muscle myosin.

Authors:  Doris Hellerschmied; Anita Lehner; Nina Franicevic; Renato Arnese; Chloe Johnson; Antonia Vogel; Anton Meinhart; Robert Kurzbauer; Luiza Deszcz; Linn Gazda; Michael Geeves; Tim Clausen
Journal:  Nat Commun       Date:  2019-10-21       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.